CD8A and neoplasm: Rnf5−/− tumor-infiltrating CD4+ and CD8+ lymphocytes (TILs) also displayed greater effector function, including enhanced IFN-γ, TNF-α, and IL-2 production (Fig. 1c; Supplementary Figure 1D).